Wuhan Hiteck Biological Pharma Co Ltd Sustainability Reports
The company researches, develops, manufactures, and markets biopharmaceutical and chemical products, notably specializing in nervous system and oncology therapies such as mouse nerve growth factor injections and recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligands.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
FIGI: BBG001SQ2N88
4 reports from 2021 to 2024